Second Quarter Highlights
(all comparisons made to the
-
Net sales up 53 percent to
$3.0 billion -
Operating income up 54 percent to
$284 million -
Operating EBITDA up 52 percent to
$539 million -
Net income per diluted share increase of 71 percent to
$0.94 -
Adjusted net income per diluted share increase of 42 percent to
$1.19 -
RPC Group Plc (“RPC”) integration progressing on plan; synergy target remains on track -
Reaffirmed fiscal year 2020 cash flow from operations and free cash flow guidance of
$1.4 billion and$800 million , respectively
Berry’s Chairman and CEO,
“I am happy to report we generated March quarterly records for net sales and operating EBITDA, both increasing over 50 percent to
“For the
“Our financial profile remains solid as we have a strong liquidity position with over
Consolidated Overview
Overall net sales in the quarter were
The operating income increase is primarily attributed to acquisition operating income of
The operating income increase is primarily attributed to acquisition operating income of
Engineered Materials
Engineered Materials delivered net sales of
The operating income increase is primarily attributed to a
Health, Hygiene, & Specialties
Health, Hygiene & Specialties delivered net sales of
The operating income decrease is primarily attributed to an
Cash Flow and Capital Structure
Our cash flow from operating activities was
Our total debt less cash and cash equivalents at the end of the
RPC Group Plc Acquisition
In
The legacy RPC business demonstrated a sequentially improved financial performance in the
Sale of SFL Business
In
Outlook
While certain markets have been impacted by COVID-19 and related restrictions, we are fortunate to have such a diversified portfolio with strong, stable end markets. Our guidance has assumed COVID-19 related restrictions, such as shelter-in-place orders, continue for the remainder of our fiscal year. We believe approximately 65 percent of our portfolio is advantaged to neutral with about 35 percent disadvantaged related to COVID-19. We expect the coronavirus to negatively impact our volumes with a low-single digit decline, but believe that we will still generate growth in EBITDA for the back half of our fiscal year driven by cost synergies and improved cost productivity. The net negative impact we are anticipating related to COVID-19 on volumes and earnings are transitory. As the restrictions are lifted, we anticipate all our segments will return to positive organic growth, as demonstrated in the most recent fiscal quarter from the pre-COVID-19 volumes and earnings levels.
We are pleased to report that we expect our fiscal year 2020 free cash flow will be in excess of
We believe the acquisition of RPC is truly a transformational and complementary opportunity for our Company and we are off to a solid start with respect to our synergy realization and integration activities. We intend to realize approximately
Investor Conference Call
The Company will host a conference call today,
About Berry
Non-GAAP Financial Measures
This press release includes non-GAAP financial measures such as operating EBITDA, Adjusted EBITDA, Adjusted net income, and free cash flow. A reconciliation of these non-GAAP financial measures to comparable measures determined in accordance with accounting principles generally accepted in
Forward Looking Statements
Statements in this release that are not historical, including statements relating to the expected future performance of the Company, are considered “forward looking” within the meaning of the federal securities laws and are presented pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. You can identify forward-looking statements because they contain words such as “believes,” “expects,” “may,” “will,” “should,” “would,” “could,” “seeks,” “approximately,” “intends,” “plans,” “estimates,” “anticipates,” “outlook,” or “looking forward,” or similar expressions that relate to our strategy, plans, or intentions. All statements we make relating to our estimated and projected earnings, margins, costs, expenditures, cash flows, growth rates, and financial results or to our expectations regarding future industry trends are forward-looking statements. In addition, we, through our senior management team, from time to time make forward-looking public statements concerning our expected future operations and performance and other developments. These forward-looking statements are subject to risks and uncertainties that may change at any time, and, therefore, our actual results may differ materially from those that we expected.
Important factors that could cause actual results to differ materially from our expectations, which we refer to as cautionary statements, are disclosed under “Risk Factors” and elsewhere in our Annual Report on Form 10-K and subsequent filings with the
Consolidated Statements of Income (Unaudited) (in millions of dollars, except per share data amounts) |
|||||||||||
|
Quarterly Period Ended |
|
Two Quarterly Periods Ended |
||||||||
|
|
|
|
|
|
|
|
||||
|
|
|
|
|
|
|
|
||||
Net sales |
$ |
2,975 |
|
$ |
1,950 |
|
$ |
5,791 |
|
$ |
3,922 |
Costs and expenses: |
|
|
|
|
|
|
|
||||
Cost of goods sold |
|
2,391 |
|
|
1,578 |
|
|
4,687 |
|
|
3,197 |
Selling, general and administrative |
|
204 |
|
|
143 |
|
|
433 |
|
|
267 |
Amortization of intangibles |
|
77 |
|
|
39 |
|
|
152 |
|
|
81 |
Restructuring and transaction activities |
|
19 |
|
|
5 |
|
|
36 |
|
|
16 |
Operating income |
|
284 |
|
|
185 |
|
|
483 |
|
|
361 |
|
|
|
|
|
|
|
|
||||
Other expense, net |
— |
|
|
23 |
|
|
13 |
|
|
23 |
|
Interest expense, net |
|
111 |
|
|
66 |
|
|
229 |
|
|
130 |
Income before income taxes |
|
173 |
|
|
96 |
|
|
241 |
|
|
208 |
Income tax expense |
|
47 |
|
|
22 |
|
|
68 |
|
|
46 |
Net income |
$ |
126 |
|
$ |
74 |
|
$ |
173 |
|
$ |
162 |
|
|
|
|
|
|
|
|
||||
Net income per share: |
|
|
|
|
|
|
|
||||
Basic |
$ |
0.95 |
|
$ |
0.57 |
|
$ |
1.31 |
|
$ |
1.24 |
Diluted |
|
0.94 |
|
|
0.55 |
|
|
1.29 |
|
|
1.21 |
|
|
|
|
|
|
|
|
||||
Outstanding weighted-average shares: (in millions) |
|
|
|
|
|
|
|
||||
Basic |
|
132.4 |
|
|
130.5 |
|
|
132.4 |
|
|
130.8 |
Diluted |
|
134.1 |
|
|
133.8 |
|
|
134.2 |
|
|
133.9 |
|
|
|
|
|
|
|
|
Condensed Consolidated Balance Sheets (Unaudited) (in millions of dollars) |
|||||
|
|
|
|
||
Assets: |
|
|
|
||
Cash and cash equivalents |
$ |
953 |
|
$ |
750 |
Accounts receivable, net |
|
1,537 |
|
|
1,526 |
Inventories |
|
1,366 |
|
|
1,324 |
Other current assets |
|
197 |
|
|
157 |
Property, plant, and equipment, net |
|
4,467 |
|
|
4,714 |
|
|
8,429 |
|
|
7,998 |
Total assets |
$ |
16,949 |
|
$ |
16,469 |
|
|
|
|
||
Liabilities and Stockholders' Equity: |
|
|
|
||
Current liabilities, excluding debt |
$ |
2,130 |
|
$ |
1,935 |
Current and long-term debt |
|
11,115 |
|
|
11,365 |
Other long-term liabilities |
|
2,053 |
|
|
1,551 |
Stockholders’ equity |
|
1,651 |
|
|
1,618 |
Total liabilities and stockholders' equity |
$ |
16,949 |
|
$ |
16,469 |
Condensed Consolidated Statements of Cash Flows (Unaudited) (in millions of dollars) |
|||||||
|
Two Quarterly Periods Ended |
||||||
|
|
|
|
||||
|
|
|
|
||||
Cash flows from operating activities: |
|
|
|
||||
Net cash from operating activities |
|
533 |
|
|
|
331 |
|
|
|
|
|
||||
Cash flows from investing activities: |
|
|
|
||||
Additions to property, plant, and equipment, net |
|
(263 |
) |
|
|
(167 |
) |
Other investing activities |
|
(10 |
) |
|
— |
||
Settlement of net investment hedges |
|
246 |
|
|
— |
||
Net cash from investing activities |
|
(27 |
) |
|
|
(167 |
) |
|
|
|
|
||||
Cash flows from financing activities: |
|
|
|
||||
Repayments on long-term borrowings |
|
(1,484 |
) |
|
|
(122 |
) |
Proceeds from long-term borrowings |
|
1,202 |
|
|
— |
||
Proceeds from issuance of common stock |
|
3 |
|
|
|
20 |
|
Debt financing costs |
|
(17 |
) |
|
— |
||
Repurchase of common stock |
— |
|
|
(74 |
) |
||
Payment of tax receivable agreement |
— |
|
|
(16 |
) |
||
Net cash from financing activities |
|
(296 |
) |
|
|
(192 |
) |
Effect of currency translation on cash |
|
7 |
|
|
— |
||
Net change in cash and cash equivalents |
|
203 |
|
|
|
(28 |
) |
Cash and cash equivalents at beginning of period |
|
750 |
|
|
|
381 |
|
Cash and cash equivalents at end of period |
$ |
953 |
|
|
$ |
353 |
|
Condensed Consolidated Financial Statements Segment Information (Unaudited) (in millions of dollars) |
|||||||||||||||
|
Quarterly Period Ended |
||||||||||||||
|
Consumer Packaging - International |
|
Consumer Packaging
- |
|
Health, Hygiene & Specialties |
|
Engineered Materials |
|
Total |
||||||
Net sales |
$ |
1,095 |
|
|
$ |
706 |
|
$ |
576 |
|
$ |
598 |
|
$ |
2,975 |
|
|
|
|
|
|
|
|
|
|
||||||
Operating income |
$ |
61 |
|
|
$ |
83 |
|
$ |
52 |
|
$ |
88 |
|
$ |
284 |
Depreciation and amortization |
|
80 |
|
|
|
64 |
|
|
44 |
|
|
25 |
|
|
213 |
Restructuring and transaction activities (1) |
|
14 |
|
|
|
3 |
|
|
1 |
|
|
1 |
|
|
19 |
Other non-cash charges (2) |
|
20 |
|
|
|
1 |
|
|
— |
|
|
2 |
|
|
23 |
Operating EBITDA |
$ |
175 |
|
|
$ |
151 |
|
$ |
97 |
|
$ |
116 |
|
$ |
539 |
|
|
|
|
|
|
|
|
|
|
||||||
|
Quarterly Period Ended |
||||||||||||||
|
Consumer Packaging - International |
|
Consumer Packaging - North America |
|
Health, Hygiene & Specialties |
|
Engineered Materials |
|
Total |
||||||
Net sales |
$ |
50 |
|
|
$ |
639 |
|
$ |
642 |
|
$ |
619 |
|
$ |
1,950 |
|
|
|
|
|
|
|
|
|
|
||||||
Operating income |
$ |
(5 |
) |
|
$ |
62 |
|
$ |
54 |
|
$ |
74 |
|
$ |
185 |
Depreciation and amortization |
|
4 |
|
|
|
53 |
|
|
46 |
|
|
29 |
|
|
132 |
Restructuring and transaction activities (1) |
|
8 |
|
|
|
4 |
|
|
6 |
|
|
4 |
|
|
22 |
Other non-cash charges (2) |
— |
|
5 |
5 |
5 |
15 |
|||||||||
Operating EBITDA |
$ |
7 |
|
|
$ |
124 |
|
$ |
111 |
|
$ |
112 |
|
$ |
354 |
(1) |
The current quarter primarily includes transaction activity costs related to the RPC acquisition. The prior year quarter primarily includes restructuring and transaction related costs related to the |
(2) |
Other non-cash charges for the |
* Prior year has been restated to match our current structure. |
|
Condensed Consolidated Financial Statements Segment Information (Unaudited) (in millions of dollars) |
|||||||||||||||
|
Two Quarterly Periods Ended |
||||||||||||||
|
Consumer Packaging - International |
|
Consumer Packaging
- |
|
Health, Hygiene & Specialties |
|
Engineered Materials |
|
Total |
||||||
Net sales |
$ |
2,105 |
|
|
$ |
1,386 |
|
$ |
1,117 |
|
$ |
1,183 |
|
$ |
5,791 |
|
|
|
|
|
|
|
|
|
|
||||||
Operating income |
$ |
105 |
|
|
$ |
133 |
|
$ |
86 |
|
$ |
159 |
|
$ |
483 |
Depreciation and amortization |
|
161 |
|
|
|
129 |
|
|
85 |
|
|
54 |
|
|
429 |
Restructuring and transaction activities (1) |
|
24 |
|
|
|
4 |
|
|
4 |
|
|
4 |
|
|
36 |
Other non-cash charges (2) |
|
27 |
|
|
|
6 |
|
|
4 |
|
|
5 |
|
|
42 |
Operating EBITDA |
$ |
317 |
|
|
$ |
272 |
|
$ |
179 |
|
$ |
222 |
|
$ |
990 |
|
|
|
|
|
|
|
|
|
|
||||||
|
Two Quarterly Periods Ended |
||||||||||||||
|
Consumer Packaging - International |
|
Consumer Packaging - North America |
|
Health, Hygiene & Specialties |
|
Engineered Materials |
|
Total |
||||||
Net sales |
$ |
101 |
|
|
$ |
1,240 |
|
$ |
1,301 |
|
$ |
1,280 |
|
$ |
3,922 |
|
|
|
|
|
|
|
|
|
|
||||||
Operating income |
$ |
(1 |
) |
|
$ |
95 |
|
$ |
100 |
|
$ |
167 |
|
$ |
361 |
Depreciation and amortization |
|
8 |
|
|
|
106 |
|
|
96 |
|
|
60 |
|
|
270 |
Restructuring and transaction activities (1) |
|
8 |
|
|
|
5 |
|
|
18 |
|
|
4 |
|
|
35 |
Other non-cash charges (2) |
|
— |
|
|
|
6 |
|
|
6 |
|
|
7 |
|
|
19 |
Operating EBITDA |
$ |
15 |
|
|
$ |
212 |
|
$ |
220 |
|
$ |
238 |
|
$ |
685 |
(1) |
Restructuring and transaction activity costs for the two quarterly periods ended |
(2) |
Other non-cash charges for the |
* Prior year has been restated to match our current structure. |
Reconciliation Schedules (Unaudited) (in millions of dollars, except per share data) |
|||||||||||
|
Quarterly Period Ended |
|
Four Quarters Ended |
||||||||
|
|
|
|
|
|
||||||
|
|
|
|
|
|
||||||
Net income |
$ |
126 |
|
|
$ |
74 |
|
|
$ |
415 |
|
Add: other expense, net |
— |
|
|
23 |
|
|
|
145 |
|
||
Add: interest expense, net |
|
111 |
|
|
|
66 |
|
|
|
428 |
|
Add: income tax expense |
|
47 |
|
|
|
22 |
|
|
|
108 |
|
Operating income |
$ |
284 |
|
|
$ |
185 |
|
|
$ |
1,096 |
|
|
|
|
|
|
|
||||||
Add: non-cash amortization from 2006 private sale |
|
6 |
|
|
|
7 |
|
|
|
27 |
|
Add: restructuring and transaction activities (2) |
|
19 |
|
|
|
22 |
|
|
|
(123 |
) |
Add: other non-cash charges (1) |
|
23 |
|
|
|
15 |
|
|
|
90 |
|
Adjusted operating income (7) |
$ |
332 |
|
|
$ |
229 |
|
|
$ |
1,090 |
|
|
|
|
|
|
|
||||||
Add: depreciation |
|
136 |
|
|
|
93 |
|
|
|
507 |
|
Add: amortization of intangibles (3) |
|
71 |
|
|
|
32 |
|
|
|
238 |
|
Operating EBITDA (6) |
$ |
539 |
|
|
$ |
354 |
|
|
$ |
1,835 |
|
|
|
|
|
|
|
||||||
Add: Pro forma adjustments (5) |
|
|
|
|
|
292 |
|
||||
Adjusted EBITDA (7) |
|
|
|
|
$ |
2,127 |
|
||||
Cash flow from operating activities |
$ |
315 |
|
|
$ |
170 |
|
$ |
1,403 |
|
|
Net additions to property, plant, and equipment |
|
(115 |
) |
|
|
(92 |
) |
|
(495 |
) |
|
Payment of tax receivable agreement |
— |
|
|
— |
|
|
(22 |
) |
|||
Free cash flow (7) |
$ |
200 |
|
|
$ |
78 |
|
$ |
886 |
|
|
|
|
|
|
|
|||||||
Net income per diluted share |
$ |
0.94 |
|
|
$ |
0.55 |
|
||||
Other expense, net |
|
— |
|
|
|
0.17 |
|
||||
Non-cash amortization from 2006 private sale |
|
0.05 |
|
|
|
0.05 |
|
||||
Restructuring and transaction activities |
|
0.14 |
|
|
|
0.17 |
|
||||
Other non-cash charges (4) |
|
0.14 |
|
|
|
— |
|
||||
Income tax impact on items above (6) |
|
(0.08 |
) |
|
|
(0.10 |
) |
||||
Adjusted net income per diluted share (7) |
$ |
1.19 |
|
|
$ |
0.84 |
|
||||
|
|
|
|
||||||||
|
Estimated Fiscal 2020 |
|
|||||||||
Cash flow from operating activities |
$ |
1,400 |
|
|
|||||||
Additions to property, plant, and equipment |
|
(600 |
) |
|
|||||||
Free cash flow (7) |
$ |
800 |
|
|
(1) |
Other non-cash charges for the |
(2) |
The current quarter primarily includes transaction activity costs related to the RPC acquisition. The prior year quarter primarily includes transaction activities related to the |
(3) |
Amortization excludes non-cash amortization from the 2006 private sale of |
(4) |
An adjustment was made only for a |
(5) |
Represents Operating EBITDA for the |
(6) |
Income tax effects on adjusted net income is calculated using 25 percent for both the |
(7) |
Supplemental financial measures that are not required by, or presented in accordance with, accounting principles generally accepted in |
We define “free cash flow” as cash flow from operating activities less additions to property, plant, and equipment and payments under the tax receivable agreement. We believe free cash flow is useful to an investor in evaluating our liquidity because free cash flow and similar measures are widely used by investors, securities analysts, and other interested parties in our industry to measure a company’s liquidity. We also believe free cash flow is useful to an investor in evaluating our liquidity as it can assist in assessing a company’s ability to fund its growth through its generation of cash. |
|
Adjusted EBITDA is used by our lenders for debt covenant compliance purposes. We also use Adjusted EBITDA and Operating EBITDA among other measures to evaluate management performance and in determining performance-based compensation. Adjusted EBITDA and Operating EBITDA and similar measures are widely used by investors, securities analysts, and other interested parties in our industry to measure a company’s performance. We also believe EBITDA and Adjusted net income are useful to an investor in evaluating our performance without regard to revenue and expense recognition, which can vary depending upon accounting methods. |
View source version on businesswire.com: https://www.businesswire.com/news/home/20200501005060/en/
Company Contact:
1+812.306.2964
ir@berryglobal.com
Source: